Live
- Reliance invests big in AP
- 2024 on track to be hottest year on record
- PM Modi’s visit to Solapur: Women applaud ‘Double-Engine’ government’s initiatives
- Nagarkurnool MLA Dr. Kuchukulla Rajesh Reddy Campaigning in Maharashtra Elections
- Wife Kills Husband with Her Lover: Details of Veldanda Murder Case Revealed by SP Gaikwad
- Strict Action on Violations of Food Rights: Telangana Food Commission Chairman Goli Srinivas Reddy
- Smooth Conduct of Group-3 Exams with Strict Security Measures: Collector Badavath Santosh
- Delhi HC orders cancellation of LOC issued against Ashneer Grover, wife
- Shami’s absence a major blow for India in BGT, says Paul Adams
- Will organize protests at borders if attack on minority Hindus in Bangladesh not stopped: Bengal LoP
Natco Pharma shares drop 3%
Shares of Natco Pharma on Wednesday dropped over 3 per cent after the company reported 35 per cent decline in consolidated net profit for the quarter ended September 30, 2019.
New Delhi: Shares of Natco Pharma on Wednesday dropped over 3 per cent after the company reported 35 per cent decline in consolidated net profit for the quarter ended September 30, 2019.
The scrip fell 3.39 per cent to close at Rs 560.80 on the BSE. During the day, it tumbled 6.71 per cent to Rs 541.50. On the NSE, it declined 3.20 per cent to close at Rs 560.05.
Natco Pharma on Tuesday reported 35 per cent decline in consolidated net profit at Rs 117.7 crore for the quarter ended September 30, 2019.
The Hyderabad-based company had posted a profit of Rs 181.1 crore in the year-ago period. Total income stood at Rs 518.9 crore for the quarter under review as against Rs 583.5 crore in the year-ago period, a decline of 11 per cent, Natco Pharma said in a BSE filing.
